Tomonaga Ameku

Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients

Toshiaki Hitomi, Toshiyuki Habu, Hatasu Kobayashi et al. · Biochemical and Biophysical Research Communications · 2013 · 126 citations

Induced Pluripotent Stem Cell, Angiogenesis, Medicine +10

The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality

Toshiaki Hitomi, Toshiyuki Habu, Hatasu Kobayashi et al. · Biochemical and Biophysical Research Communications · 2013 · 60 citations

Disease Mechanism, Genetic Disorder, Genetics +8

Identification of MMP1 as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models

Tomonaga Ameku, Daisuke Taura, Masakatsu Sone et al. · Scientific Reports · 2016 · 38 citations · Full text

Rho-Associated Kinases and Non-muscle Myosin IIs Inhibit the Differentiation of Human iPSCs to Pancreatic Endoderm

Tarō Toyoda, Azuma Kimura, Hiromi Tanaka et al. · Stem Cell Reports · 2017 · 25 citations · Full text

Transcriptional Analysis of Intravenous Immunoglobulin Resistance in Kawasaki Disease Using an Induced Pluripotent Stem Cell Disease Model

Kazuyuki Ikeda, Yasutaka Mizoro, Tomonaga Ameku et al. · Circulation Journal · 2016 · 15 citations · Full text